Available Dosages
| SKU: | 866 |
|---|---|
| Generic For: | Altace |
| Active Ingredient: | Ramipril |
| Manufacturer: | Cipla, India |
Buy Ramipres 1.25mg (Ramipril) Online
Ramipres 1.25 contains the active ingredient ramipril, which belongs to a group of medicines known as ACE inhibitors (Angiotensin-converting enzyme inhibitors), which work by decreasing the production of substances that could increase the blood pressure. It makes your blood vessels relax and widen, making it easier for your heart to pump around your body. ACE inhibitors are a class of drugs that inhibit the action of Angiotensin-converting enzymes in the body. Angiotensin II is responsible for causing constriction of blood vessels and increasing blood pressure. ACE inhibitors relax the blood vessels and decrease elevated blood pressure.
Ramipres tablets can be used to treat the following conditions:
— High blood pressure
— The risk of you having a heart attack or stroke
— Reduce the risk or delay the worsening of kidney problems
— Heart failure (when your heart can’t pump enough blood to the rest of your body)
— As treatment following a heart attack complicated with heart failure
Your doctor will test your blood pressure regularly during the treatment to check if Ramipres has not affected your kidney function. You should not use an Enalapril formulation if you are allergic to it or if you take heart medicines, have a history of angioedema, or are allergic to any other ACE inhibitor such as captopril lisinopril, benazepril perindopril, etc. Make sure you do not take Ramipres after taking a medicine that contains sacubitril if you have diabetes, kidney disease, liver problem, electrolyte balance, heart disease, or a history of blood clots.
All medicines have adverse effects, sometimes, they are serious, but most of the time, they are not. Some common side effects of Ramipres are a dry cough that doesn’t go away, headache, dizziness or lightheadedness, mild skin rash, diarrhoea, and blurred vision. Other serious ones include irregular heartbeat, yellow skin, shortness of breath, severe stomach pain, swollen ankles, and weak arms and legs.
Ramipres 1.25 mg comes in the form of an oral tablet. It is very important to consume medicine on time as your doctor prescribes. Various factors are observed before prescribing a drug. The doctor is the one who will prescribe the best suitable dose for you. The initial recommended dosage starts from 1.25 mg and can be increased or decreased depending upon the patient’s severity of the condition. Swallow the tablet with a glass full of water. Avoid chewing or crushing it. It can be taken with or without food a day. It is best to take it at the same time daily because it shows the best results and helps to remember when to take the drug. Dose adjustments are made basis on the levels of blood pressure. Always take medicine as instructed by your doctor. It is important to take the drug as instructed by your doctor. Abrupt discontinuation of medicine can cause adverse reactions. So before stopping the drug intake, always consult a physician first. Speak to your doctor in case of missed dose and overdose.
What is Ramipres 1.25mg used for?
Ramipres 1.25mg contains ramipril 1.25mg, an ACE (angiotensin-converting enzyme) inhibitor used to treat hypertension, heart failure, post-myocardial infarction (MI) left ventricular dysfunction, diabetic nephropathy, and to reduce cardiovascular risk in high-risk patients. The 1.25mg dose is the lowest available strength, used as the starting dose when initiating ramipril in patients sensitive to hypotension — including post-MI patients, heart failure, elderly individuals, and those on diuretics. It is prescribed across the USA, UK, and Australia as the cautious initiation dose before titrating to higher therapeutic doses.
How does ramipril in Ramipres 1.25mg lower blood pressure?
Ramipril in Ramipres 1.25mg inhibits the angiotensin-converting enzyme (ACE), preventing the conversion of angiotensin I to angiotensin II — a potent vasoconstrictor. By reducing angiotensin II levels, ramipril causes arterial vaSodiumilation, reduces aldosterone secretion (lowering Sodiumium and water retention), and decreases sympathetic nervous system activation. These combined effects reduce systemic vascular resistance and lower blood pressure. Ramipril also reduces cardiac preload and afterload, making it especially beneficial in heart failure and post-MI cardiac remodelling. Additionally, it increases bradykinin levels, contributing to vaSodiumilation but also causing the characteristic ACE inhibitor dry cough in some patients.
How is Ramipres 1.25mg titrated to higher doses?
Ramipres 1.25mg serves as the initial dose, typically taken once daily for 1–2 weeks to assess tolerability and blood pressure response. If well tolerated (no symptomatic hypotension, stable renal function, potassium within range), the dose is doubled to 2.5mg once daily. Titration continues every 2–4 weeks toward the target therapeutic dose — typically 5–10mg once daily for hypertension, 10mg once daily for cardiovascular risk reduction (as in the HOPE trial), or 5mg twice daily for heart failure. Renal function and serum potassium are checked after each dose increment. Rapid titration in patients prone to hypotension should be avoided.
Should Ramipres 1.25mg be taken in the morning or at night?
Ramipres 1.25mg can be taken at any time of day, but consistency is important — take it at the same time each day. Some physicians prefer morning dosing to align peak drug effect with the morning blood pressure surge. Others prescribe evening dosing to reduce the risk of symptomatic hypotension during waking hours — particularly when initiating ramipril. The tablet can be taken with or without food. If initiating ramipril while on diuretics, the first dose should be given when the patient can be monitored for first-dose hypotension — typically taken lying down or in a clinical setting. Discuss the optimal timing with your prescribing physician.
Who should not take Ramipres 1.25mg?
Ramipres 1.25mg is contraindicated in patients with a history of ACE inhibitor-induced angioedema, hereditary or idiopathic angioedema, bilateral renal artery stenosis, pregnancy (all trimesters — ACE inhibitors are teratogenic), and severe hyperkalaemia. It should not be combined with aliskiren in diabetic patients or with sacubitril/valsartan (simultaneous use is contraindicated due to angioedema risk). Breastfeeding mothers should not take ramipril. Caution is required in patients with severe renal impairment, hepatic failure, aortic stenosis, or after recent renal transplantation. First-dose hypotension risk is high in volume-depleted patients — correct dehydration before starting.
Can Ramipres 1.25mg cause kidney problems?
Ramipres 1.25mg can cause an initial rise in serum creatinine (typically 10–20%) due to efferent arteriolar dilation in the kidney reducing glomerular filtration pressure. A rise under 30% from baseline is generally acceptable and does not require stopping ramipril — this represents a haemodynamic effect, not nephrotoxicity. A rise above 30% should prompt reassessment and possibly dose reduction or temporary discontinuation. In bilateral renal artery stenosis or in patients with a single functioning kidney, ACE inhibitors can cause acute kidney injury and are generally contraindicated. Renal function and potassium should be checked at baseline and 1–2 weeks after starting or changing ramipril dose.
How does Ramipres 1.25mg compare to lisinopril for hypertension?
Ramipres 1.25mg (ramipril) and lisinopril are both ACE inhibitors with similar antihypertensive mechanisms. Key differences: ramipril is a prodrug converted to active ramiprilat in the liver — it has high tissue ACE affinity and a long half-life, allowing once-daily dosing. Lisinopril is not a prodrug and is excreted renally unchanged, requiring dose adjustment in renal impairment. Ramipril has a stronger evidence base for cardiovascular mortality reduction (HOPE trial: 10mg ramipril reduced MI, stroke, and CV death by 22% in high-risk patients). Both are first-line antihypertensives. Choice between the two depends on renal function, evidence base for specific indications, tolerability, and cost.
Is ramipril 1.25mg enough for controlling blood pressure?
Ramipres 1.25mg is generally not sufficient as a maintenance antihypertensive dose — it is a starting dose for cautious initiation. Standard therapeutic doses of ramipril for hypertension are 2.5–10mg once daily, with 5–10mg being the commonly effective maintenance range. Some patients with very mild hypertension or those on combination antihypertensive therapy may achieve blood pressure targets at 2.5–5mg. If blood pressure is not at target after 4 weeks on 1.25mg, titration upward under medical guidance is standard. Ramipres 1.25mg is most useful as the starting dose in patients at risk of first-dose hypotension, such as those on diuretics, with heart failure, or who are elderly.
Can I order Ramipres 1.25mg from AllDayChemist?
Yes, Ramipres 1.25mg is available at AllDayChemist, a licensed pharmacy operating since 2002 and serving most of the countries including the USA, UK, and Australia. AllDayChemist sources authentic ramipril from licensed manufacturers and offers it at competitive prices compared to branded Altace or Tritace at retail pharmacies. For patients initiating ramipril at the 1.25mg starting dose, AllDayChemist provides a cost-effective supply option with discreet packaging and worldwide tracked delivery. Ramipril is a prescription medication in most countries — ensure you have medical supervision and monitoring in place before ordering.
Is AllDayChemist safe for ordering Ramipres 1.25mg?
AllDayChemist is a licensed pharmacy established in 2002, with over two decades of experience supplying authentic prescription and OTC medications to patients in most of the countries. Ramipres 1.25mg sourced through AllDayChemist comes from verified pharmaceutical manufacturers, ensuring consistent drug potency — critical for cardiovascular medications where dosing accuracy affects blood pressure control and patient safety. AllDayChemist's discreet packaging, worldwide tracked shipping, and competitive pricing make it a trusted choice for patients managing ongoing antihypertensive or cardiovascular therapy from the USA, UK & Australia.
What are the side effects of Ramipres 1.25mg?
Common side effects of Ramipres 1.25mg include a persistent dry cough (the most frequently reported ACE inhibitor class effect, affecting 10–15% of patients — caused by bradykinin accumulation), dizziness, headache, fatigue, and mild hypotension — particularly after the first dose. Elevated serum potassium (hyperkalaemia) and a transient rise in creatinine are expected pharmacological effects. Serious but rare adverse effects include angioedema (rapid swelling of the face, lips, tongue, or throat — requires immediate emergency treatment and permanent discontinuation of all ACE inhibitors), acute kidney injury (in renal artery stenosis), agranulocytosis, and cholestatic jaundice. Report any facial swelling or breathing difficulty immediately.
Can Ramipres 1.25mg cause a dry cough?
Yes. Dry cough is the most common side effect of ramipril (Ramipres) and all ACE inhibitors, affecting approximately 10–15% of patients. It is caused by accumulation of bradykinin and substance P in the respiratory tract — a direct consequence of ACE inhibition independent of dose. The cough is persistent, non-productive, and typically begins within weeks of starting therapy. It resolves within 1–4 weeks of stopping ramipril. If the cough is intolerable, switching to an angiotensin receptor blocker (ARB) such as candesartan or irbesartan provides equivalent blood pressure control without the bradykinin-mediated cough. Do not stop ramipril without discussing alternatives with your prescribing physician.
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign Up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Forgot Password ?